Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis

BACKGROUND: Clinical efficacy of immune checkpoint inhibitors (ICIs) for non-small cell lung cancer (NSCLC) with uncommon histology (uNSCLC) is unknown. METHODS: Patients with NSCLC treated with ICI monotherapy between January 2014 and December 2018 in 10 Japanese hospitals were retrospectively eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyashita, Koichi, Karayama, Masato, Inoue, Yusuke, Hozumi, Hironao, Suzuki, Yuzo, Furuhashi, Kazuki, Fujisawa, Tomoyuki, Enomoto, Noriyuki, Nakamura, Yutaro, Kono, Masato, Matsui, Takashi, Niwa, Mitsuru, Koda, Keigo, Toyoshima, Mikio, Matsushima, Sayomi, Matsuura, Shun, Asada, Kazuhiro, Fujii, Masato, Kusagaya, Hideki, Matsuda, Hiroyuki, Inui, Naoki, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487118/
https://www.ncbi.nlm.nih.gov/pubmed/34600514
http://dx.doi.org/10.1186/s12890-021-01681-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487118/
https://www.ncbi.nlm.nih.gov/pubmed/34600514
http://dx.doi.org/10.1186/s12890-021-01681-6

Ejemplares similares